REFORM study: Reviewing Effects of Vildagliptin-Dapagliflozin FDC on HbA1c & Weight in Type 2 Diabetes Management MD Brand Connect17 Jan 2025 12:00 PM ISTThe fixed-dose combination (FDC) of Vildagliptin 100mg SR and Dapagliflozin 10mg showed significant glycemic control, weight reduction, and favorable...
Metformin Outperforms Vildagliptin in Reducing BMI and Weight in T2D Patients: Study Dr Riya Dave24 Dec 2024 9:00 AM ISTResearchers have found that both vildagliptin and metformin reduce hepatic steatosis effectively and improve glycemic control in newly diagnosed type...
Insights from "EVER-Vilda", Expert Perspective on Vildagliptin's Applicability in Indian T2DM Patients MDTV Bureau14 March 2024 2:45 AM ISTThe "EVER-Vilda" opinion paper is an Indian expert's evaluation of the efficacy and rationality of vildagliptin. It underscores vildagliptin's...
CDSCO nod to Synokem Pharma for marketing, manufacturing antidiabetic FDC Pioglitazone, Vildagliptin Isra Zaman4 Sept 2023 2:21 PM ISTWith the condition of conducting phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Health Bulletin 02/September/2023 Isra Zaman2 Sept 2023 4:19 PM ISTHere are the Top health stories for the day:Death of pregnant doctor due to delayed medical attention: HC sets aside WBCERC order, directs...
Synokem Gets CDSCO Panel Nod To Manufacture, Market antidiabetic FDC Pioglitazone, Vildagliptin Dr. Divya Colin31 Aug 2023 6:00 PM ISTNew Delhi: With the condition of conducting phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
USV Launches Jalra Trio for Management of Type 2 Diabetes in India MD Brand Connect11 Aug 2023 12:22 PM ISTUSV Pvt. Ltd, a leading drug manufacturer in the anti-diabetic segment, has announced the launch of the brand Jalra Trio for the treatment of...
ADA Releases Guidelines Update for Screening and Treatment NAFLD in Type 2 Diabetes, Check Out Details Dr. Kamal Kant Kohli28 July 2023 11:32 AM ISTUnderstanding the close interaction between Non-Alcoholic Fatty Liver Disease & Type 2 Diabetes, and continuously evolving evidence, the American...
Alkem Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug Dr. Divya Colin6 Jun 2023 6:00 PM ISTNew Delhi: The drug major Alkem Laboratories has got the green signal from the Subject Expert Committee (SEC) functional under Central Drug Standard...
A Novel Therapeutic Approach for Managing Hidden Epidemic of FLA1c in Patients with T2DM Dr. Kamal Kant Kohli31 May 2023 10:15 AM ISTNon-alcoholic fatty liver disease (NAFLD) affects up to one-third of the general population worldwide. Type 2 diabetes mellitus (T2DM) and obesity...
Interim Analysis of Real-world patient experience of Vildagliptin 100mg SR OD in terms of Glycaemic Variability out now Dr. Nandita Mohan4 May 2023 11:15 AM ISTA recent prospective, multicentric, observational study conducted in patients with diabetes assessed the real-world experience of Vildagliptin 100mg...
USV launches Pioz-V for uncontrolled diabetic patients with fatty liver Dr. Nandita Mohan25 April 2023 2:09 PM ISTMumbai: USV Pvt. Ltd, a leading drug manufacturer in the anti-diabetic segment, has announced the launch of the brand Pioz-V for the treatment of...
